THYROCARE TECHNOLOGIES LIMITED Thyrocare Technologies Limited Stock
Equities
THYROCARE
INE594H01019
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 628 INR | -0.15% |
|
-3.28% | -2.41% |
| May. 14 | Transcript : Thyrocare Technologies Limited, Q4 2024 Earnings Call, May 14, 2024 | |
| May. 14 | Thyrocare Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| Sales 2024 | 5.72B 68.89M | Sales 2025 * | 6.5B 78.35M | Capitalization | 33.25B 401M |
|---|---|---|---|---|---|
| Net income 2024 | 708M 8.53M | Net income 2025 * | 884M 10.65M | EV / Sales 2024 | 5.48 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.11 x |
| P/E ratio 2024 |
44.2
x | P/E ratio 2025 * |
37.6
x | Employees | 1,645 |
| Yield 2024 * |
1.35% | Yield 2025 * |
1.61% | Free-Float | 27.38% |
More Fundamentals
* Assessed data
More news
Latest transcript on Thyrocare Technologies Limited
| 1 day | -0.15% | ||
| 1 week | -3.28% | ||
| Current month | -2.45% | ||
| 1 month | -2.45% | ||
| 3 months | +1.05% | ||
| 6 months | +14.00% | ||
| Current year | -2.41% |
1 week
620.00
653.00
1 month
598.45680.90
Current year
555.85722.00
1 year
449.95722.00
3 years
416.001 465.90
5 years
406.651 465.90
10 years
406.651 465.90
| Managers | Title | Age | Since |
|---|---|---|---|
Rahul Guha
CEO | Chief Executive Officer | - | 22-05-03 |
| Director of Finance/CFO | - | 23-08-08 | |
Ramjee Dorai
CMP | Compliance Officer | 67 | 14-08-17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 14-08-20 | |
| Director/Board Member | 54 | 14-09-19 | |
| Director/Board Member | - | 21-10-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 112 M€ | +4.47% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 628 | -0.15% | 611 |
| 24-05-23 | 629 | +0.03% | 3,615 |
| 24-05-22 | 628.8 | -0.87% | 821 |
| 24-05-21 | 634.2 | -1.42% | 1,666 |
| 24-05-18 | 643.4 | -0.87% | 397 |
Delayed Quote Bombay S.E., May 24, 2024 at 06:00 am EDT
More quotes
Thyrocare Technologies Limited is an India-based healthcare services provider in diagnostic area. The Company has diagnostic chains that conduct a range of medical diagnostic tests and profiles of tests that is focused on early detection and management of health disorders and diseases. The Company's segments include Diagnostic Testing Services, Imaging Services and Others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services includes diagnostic and imaging services, selling of radio-pharmaceutical, selling of consumables for reporting. The Others segment include the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. The Company has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India.
Calendar
2024-07-30
- Q1 2025 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
628
INR
Average target price
740
INR
Spread / Average Target
+17.83%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.41% | 400M | |
| -23.07% | 8.1B | |
| +68.10% | 4.26B | |
| +1.88% | 2.57B | |
| -8.06% | 2.49B | |
| -41.95% | 2.39B | |
| -11.59% | 1.77B | |
| -20.95% | 1.53B | |
| +17.44% | 1.2B | |
| -43.89% | 1.18B |
- Stock Market
- Equities
- THYROCARE Stock
